Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

GobyMeds vs Rylo Health

GobyMeds
Graded #140

Higher grade

vs+4.200000000000003
Rylo Health
Graded #240

Lower grade

The verdict

GobyMeds takes it — 68.9/100 to 64.7/100.

GobyMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Affordable telehealth provider offering compounded semaglutide only.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGobyMeds +3
67
64
Dose & formulationGobyMeds +11
75
64
Clinical oversightGobyMeds +7
82
75
Labs & monitoringEven
53
53
FulfillmentRylo Health +13
70
83
Contract termsGobyMeds +18
55
37
GobyMeds · left barRylo Health · right bar

The numbers

MetricGobyMedsRylo Health
WeighScore68.9/10064.7/100
GradeCC
Scorecard rank#140#240
Semaglutide$169/mo (all doses, compounded)$149/mo (promotional rate, compounded)
Tirzepatide$299/mo (all doses, compounded)$249/mo (compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
GobyMeds

Graded #140 · C

Strengths

  • Aggressively low monthly pricing
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Rylo Health

Graded #240 · C

Strengths

  • Names its dispensing pharmacy in full, with address and phone: VialsRX in Houston, Texas
  • Names its medical group, Lone Star Virtual Health PLLC, and gives a provider contact
  • Standard prices published openly alongside the promotional rate, so the real ongoing cost is visible
  • Cancel in one click from the patient portal, with no contracts and no cancellation fees
  • Peptide line priced openly, including NAD+ and sermorelin

Where it loses points

  • Headline $100 and $160 rates are limited to the first 20 patients; standard rates are $149 and $249
  • No LegitScript certification is claimed or displayed
  • Several peptide products are advertised as coming soon rather than available
  • No published refund policy beyond the no-cancellation-fee statement

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard